project-logo

ARNA Panacea

ICO starts
15.12.2017 00:00
ICO ends
10.02.2018 00:00
Start Bonus
50%
Token
ARNA
Base
Ethereum
Category
Science & Research
Country
Russia
Leader

Features

ARNA Panacea is platform which allows not processing of clinical trials data and also support for researchers during R&D phase and marketplace for all types of market participants involved in clinical trials as well as direct sales of final biotech products to customers (patients). The platform’s initial purpose is to gain, store and analyze information on all the methods of cancer detection and treatment from all over the world. This would allow researchers getting more accurate and precise knowledge on the subject on one hand, and on the other — will provide trustable and accessible proof to all market participants on research results conducted throughout their lifecycle.

ICO Details

Token Sales

Regulator and launch of ARNA BC - 50%
Development and implementation of ARNA Panacea - 17,3%
R&D - 14,1%
Legal support costs - 5%
Operational expenses including marketing - 13,5%

Accepts

ETH

Subscribe to ICO BASE news

Be the first who get site's updates and other new features